Akari Therapeutics (AKTX) Income Statement (2014 - 2025)
Income Statement report data from Mar 31, 2014 to Sep 30, 2025 for Akari Therapeutics (AKTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||||||||||||||
Research And Development | 250K (-62.69%) | 670K (-17.28%) | 810K (-35.20%) | 1.25M (+792.86%) | 140K (-95.77%) | 3.31M (+45.18%) | 2.28M (-9.16%) | 2.51M | -310.00K | 1.52M (-12.14%) | 1.73M (+15.33%) | 1.50M (-46.24%) | 2.79M (+112.98%) | 1.31M (+835.71%) | 140K (-90.97%) | 1.55M (-60.36%) | 3.91M (+2343.75%) | 160K (-89.61%) | 1.54M (+92.50%) | 800K |
Selling General And Administrative | 1.98M (-19.18%) | 2.45M (-9.59%) | 2.71M (+35.50%) | 2.00M (+16.96%) | 1.71M (-23.66%) | 2.24M (-39.62%) | 3.71M (+43.80%) | 2.58M (-8.51%) | 2.82M (-8.74%) | 3.09M (+8.04%) | 2.86M (+21.70%) | 2.35M (+72.79%) | 1.36M (-50.18%) | 2.73M (+108.40%) | 1.31M (+1210.00%) | 100K (-94.54%) | 1.83M (+2950.00%) | 60K (-92.41%) | 790K (-26.85%) | 1.08M |
Operating Expenses | 2.22M (-28.85%) | 3.12M (-11.61%) | 3.53M (-57.21%) | 8.25M (+345.95%) | 1.85M (-66.73%) | 5.56M (-7.18%) | 5.99M (+17.68%) | 5.09M (+102.79%) | 2.51M (-45.67%) | 4.62M (+0.65%) | 4.59M (+19.22%) | 3.85M (-7.23%) | 4.15M (-82.21%) | 23M (+1497.95%) | 1.46M (-11.52%) | 1.65M | -2.51M | 220K (-90.56%) | 2.33M (+23.94%) | 1.88M |
Depreciation And Amortization | - | - | - | - | - | - | 10K | - | - | - | - | 10K (0.00%) | 10K | - | - | - | 10K | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -7.40M (+137.18%) | -3.12M (-11.36%) | -3.52M (-33.33%) | -5.28M (+80.20%) | -2.93M (-60.67%) | -7.45M (+24.37%) | -5.99M (+17.68%) | -5.09M (+102.79%) | -2.51M (-45.55%) | -4.61M (+0.44%) | -4.59M (+19.22%) | -3.85M (-7.23%) | -4.15M (-82.21%) | -23.33M (+1497.95%) | -1.46M (-11.52%) | -1.65M (-71.30%) | -5.75M (+2513.64%) | -220.00K (-90.56%) | -2.33M (+23.94%) | -1.88M |
Ebit | -7.40M (+137.18%) | -3.12M (-11.36%) | -3.52M (-33.33%) | -5.28M (+80.20%) | -2.93M (-60.67%) | -7.45M (+24.37%) | -5.99M (+17.68%) | -5.09M (+102.79%) | -2.51M (-45.55%) | -4.61M (+0.44%) | -4.59M (+19.22%) | -3.85M (-7.23%) | -4.15M (-82.21%) | -23.33M (+1497.95%) | -1.46M (-11.52%) | -1.65M (-71.30%) | -5.75M (+2513.64%) | -220.00K (-90.56%) | -2.33M (+23.94%) | -1.88M |
EBITDA | -7.39M (+301.63%) | -1.84M (-49.59%) | -3.65M (-31.39%) | -5.32M (+87.99%) | -2.83M (-62.32%) | -7.51M (+25.59%) | -5.98M (+11.99%) | -5.34M (+86.06%) | -2.87M (-28.25%) | -4.00M (-12.85%) | -4.59M (+19.53%) | -3.84M | 18M | -45.68M (+2635.33%) | -1.67M (+1.21%) | -1.65M (-71.75%) | -5.84M (+2554.55%) | -220.00K (-90.13%) | -2.23M (+18.62%) | -1.88M |
Other Income / Expenses | ||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | 10K (-50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (+50.00%) | 20K | - | - | - | - | - | - | - |
Interest Expense | 100K (+100.00%) | 50K (-16.67%) | 60K (-50.00%) | 120K (+71.43%) | 70K (+40.00%) | 50K | - | - | - | - | - | - | - | 3.05M | - | - | - | - | - | - |
Net Interest Income | -100.00K | - | - | 50K | - | -50.00K | - | 10K (-50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (+50.00%) | 20K | -3.05M | - | - | - | - | - | - |
Other Non Operating Income | -80.00K | 1.22M | -180.00K | - | 30K | -110.00K | - | -20.00K (0.00%) | -20.00K (+100.00%) | -10.00K (0.00%) | -10.00K | 870K | -14.73M (-42.03%) | -25.41M (+12000.00%) | -210.00K (-60.38%) | -530.00K | 530K | -10.00K | 100K (-28.57%) | 140K |
Net Income | ||||||||||||||||||||
Income Before Tax | -7.49M | - | - | -16.90M (+484.78%) | -2.89M | - | - | -10.01M | - | - | - | -2.99M | 6.79M | -48.74M (+2818.56%) | -1.67M (-1.76%) | -1.70M | 2.24M | -220.00K (-90.13%) | -2.23M (+28.16%) | -1.74M |
Income Tax Expense | -1.09M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -6.40M (+238.62%) | -1.89M (-48.92%) | -3.70M (-1.86%) | -3.77M (+30.45%) | -2.89M (-61.77%) | -7.56M (+35.73%) | -5.57M (+34.54%) | -4.14M (+44.25%) | -2.87M (-28.25%) | -4.00M | 1.00M | -2.99M | 6.79M | -48.74M (+2818.56%) | -1.67M (-1.76%) | -1.70M (-68.86%) | -5.46M (+2381.82%) | -220.00K (-90.13%) | -2.23M (+28.16%) | -1.74M |
Net Income | -6.40M (+238.62%) | -1.89M (-48.92%) | -3.70M (-1.86%) | -3.77M (+30.45%) | -2.89M (-61.77%) | -7.56M (+35.73%) | -5.57M (+34.54%) | -4.14M (+44.25%) | -2.87M (-28.25%) | -4.00M | 1.00M | -2.99M | 6.79M | -48.74M (+2818.56%) | -1.67M (-1.76%) | -1.70M (-68.86%) | -5.46M (+2381.82%) | -220.00K (-90.13%) | -2.23M (+28.16%) | -1.74M |
Comprehensive Income Net Of Tax | -6.44M (+188.79%) | -2.23M (-40.37%) | -3.74M (-80.81%) | -19.49M (+534.85%) | -3.07M (-59.34%) | -7.55M (+42.72%) | -5.29M (-48.54%) | -10.28M (+258.19%) | -2.87M (-29.31%) | -4.06M | 1.00M | -3.18M (-92.97%) | -45.21M (-7.32%) | -48.78M | - | -1.67M (-10.70%) | -1.87M (+679.17%) | -240.00K | - | - |